Anti-oxidative effects of vitamin B2-butyrate on the cardiac mitochondrial disorders induced by adriamycin.
スポンサーリンク
概要
- 論文の詳細を見る
The combined use of CoQ10 with adriamycin has beenrecommended for reduction, of the cardiotoxicity that occurs during cancer chemotherapy. Vitamin B2-butyrate was also investigated in order to determine anti-oxidative effects on adriamycin cardiotoxicity. This vitamin analysis prevented enhanced lipid peroxidation and rectified the respiratory disorders of heart mitochondria induced by adriamycin, however, the deficiency of the CoQ10-pool was not rectified. The combined approach of using CoQ10 for rectifying the deficiency of this component and of using B2-butyrate for reducing lipid peroxidation was indicated for adriamycin cancer chemotherapy.
- 財団法人 学会誌刊行センターの論文
著者
-
GRIFFIN A.
M. D. Anderson Hospital and Tumor Institute
-
小倉 良平
Department of Medical Biochemsitry, Kurume University School of Medicine
-
香月 司
Department of Medical Biochemsitry, Kurume University School of Medicine
-
DAOUD Abdulwahid
M. D. Anderson Hospital and Tumor Institute
-
小倉 良平
Department of Medical Biochemistry, Kurume University School of Medicine
関連論文
- Anti-oxidative effects of vitamin B2-butyrate on the cardiac mitochondrial disorders induced by adriamycin.
- Effect of riboflavin-butyrate on cardiac glutathione reductase affected by adriamycin.